Pharmaceutical Membrane Filtration Market will reach $7,960.3 Million by 2018

This report studies the global market over the forecast period of 2013 to 2018. This market is valued at an estimated $3,691.9 million in 2013 and is poised to grow at a CAGR of 16.6% from 2013 to 2018, to reach $7,960.3 million by 2018.

The technology segments included in the report are microfiltration, ultrafiltration, nanofiltration, reverse osmosis, and ion exchange; the application segments are cell separation, protein purification, sterilization, virus removal, and water management; while the geographic segments are North America, Europe, Asia-Pacific, and Rest of the World (RoW).

The major factor driving the growth of this market is the growth of the global pharmaceutical industry. Membrane filtration is a widely used separation technique in the pharmaceutical industry and its adoption rate in Europe and North America is high. Further, the increasing adoption rate in the Asia-Pacific segment and the increasing demand for single use technology will further drive this market. The membrane filtration market for pharmaceutical is expected to witness a high growth in the forecast period.

Membrane filtration is the most widely used technology for protein purification in the pharmaceutical industry. Other important applications of this technology in the pharmaceutical industry are cell separation and water treatment. Microfiltration and ultrafiltration are the most widely used filtration technologies in the pharmaceutical industry. In 2013, Europe was the largest market for pharmaceutical membrane filtration. However, the North American market is expected to grow rapidly in the forecast period between 2013 and 2018 and is expected to be as large as that of Europe by 2018.

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.